No Data
No Data
Earnings Preview: MBRX to Report Financial Results on March 21
$Moleculin Biotech(MBRX.US)$ is scheduled to release its financial results on March 21 ET. Earnings PreviewAnalysts estimate $Moleculin Biotech(MBRX.US)$ to post revenue of USD0.00 for 2024Q4, EPS
Moleculin to Report Full Year 2024 Financial Results on March 21, 2025 and Host Conference Call and Webcast
Virtual Investor Releases Next Wave of "Top 5 for '25" On-Demand Videos
Moleculin to Present at the 37th Annual ROTH Conference
Express News | Moleculin Biotech Inc: New Patents Will Extend Coverage to Major Markets Outside U.S.
Moleculin Biotech Received Notice Of Intent To Grant For Eurpean Patent Application Titled "Method of Reconstituting Liposomal Annamycin".